ADA American Diabetes Association DPP-4i Dipeptidyl peptidase 4 inhibitor EASD European Association for the Study of Diabetes EMA European Medicines Agency GLP-1 RA Glucagon-like peptide 1 receptor agonist MPR Medication possession ratio OAD Oral antidiabetic drug SGLT2i Sodium-glucose cotransporter 2 inhibitor SU Sulfonylurea T2D Type 2 diabetes TZD Thiazolidinedione 1 INTRODUCTION In 2021, approximately 536 million people aged 20–79 had a diagnosis of diabetes.
